Covaxin Could be Ready for June 2021 Rollout, Says Bharat Biotech

According to a report in the Indian Express, a top company official informed that Covaxin should be ready by June 2021-- unless the government advances its launch through emergency use authorisation.

"If we get all the approvals in place, I think during Q2 of 2021, we should get the efficacy readout from our phase-3 clinical trial — April, May, June, for example. That is for the full efficacy results," Sai Prasad, executive director, Bharat Biotech International Ltd, told The Indian Express.

Developed by Bharat Biotech along with the Indian Council of Medical Research and National Institute of Virology, Covaxin is India's first indigenous vaccine candidate against the Covid-19.